| New report, "Republic of Korea In Vitro Diagnostics | | | | segments and sub-segments within seven market |
| Market Outlook to 2016" provides key market data | | | | categories. Data from 2002 to 2009, forecast |
| on the Korea In Vitro Diagnostics (IVD) market. The | | | | forward for 7 years to 2016. |
| report provides value (USD million), volume (units) and | | | | - 2009 company shares and distribution shares data |
| average price (USD) data for each segment and | | | | for each of the seven market categories. |
| sub-segment within seven market categories – | | | | - Global corporate-level profiles of key companies |
| clinical chemistry, genetic testing, histology and | | | | operating within the Korea In Vitro Diagnostics (IVD) |
| cytology, immuno chemistry, infectious immunology, | | | | market. |
| microbiology culture, and haematology. The report | | | | - Key players covered include Roche, Siemens |
| also provides company shares and distribution shares | | | | Healthcare, Abbott, Beckman Coulter, Biomerieux, |
| data for each of the aforementioned market | | | | Ortho-Clinical Diagnostics, and Becton, Dickinson. |
| categories. The report is supplemented with global | | | | Reasons to buy |
| corporate-level profiles of the key market | | | | - Develop business strategies by identifying the key |
| participants with information on company financials | | | | market categories and segments poised for strong |
| and pipeline products, wherever available. | | | | growth. |
| This report is built using data and information sourced | | | | - Develop market-entry and market expansion |
| from proprietary databases, primary and secondary | | | | strategies. |
| research and in-house analysis by GlobalData's team | | | | - Design competition strategies by identifying |
| of industry experts. | | | | who-stands-where in the Korea In Vitro Diagnostics |
| Scope | | | | (IVD) competitive landscape. |
| - Market size and company share data for In Vitro | | | | - Develop capital investment strategies by identifying |
| Diagnostics (IVD) market categories – clinical | | | | the key market segments expected to register |
| chemistry, genetic testing, histology and cytology, | | | | strong growth in the near future. |
| immuno chemistry, infectious immunology, | | | | - What are the key distribution channels and what's |
| microbiology culture, and haematology. | | | | the most preferred mode of product distribution |
| - Annualized market revenues (USD million), volume | | | | – Identify, understand and capitalize. |
| (units) and average price (USD) data for each of the | | | | |